RT Journal Article
T1 Inadequate use of antibiotics in the covid-19 era: effectiveness of antibiotic therapy
A1 Bendala Estrada, Alejandro David
A1 Calderon Parra, Jorge
A1 Fernandez Carracedo, Eduardo
A1 Muino Miguez, Antonio
A1 Ramos Martinez, Antonio
A1 Munez Rubio, Elena
A1 Rubio-Rivas, Manuel
A1 Agudo, Paloma
A1 Arnalich Fernandez, Francisco
A1 Estrada Perez, Vicente
A1 Taboada Martinez, Maria Luisa
A1 Crestelo Vieitez, Anxela
A1 Pesqueira Fontan, Paula Maria
A1 Bustamante, Marta
A1 Freire, Santiago J.
A1 Oriol-Bermudez, Isabel
A1 Artero, Arturo
A1 Olalla Sierra, Julian
A1 Areses Manrique, Maria
A1 Javier Carrasco-Sanchez, H. Francisco
A1 Carolina Vento, Vanessa
A1 Garcia Garcia, Gema Maria
A1 Cubero-Morais, Pablo
A1 Casas-Rojo, Jose-Manuel
A1 Millan Nunez-Cortes, Jesus
K1 COVID-19
K1 SARS-CoV-2
K1 Antibiotics
K1 Survival
K1 Macrolides
K1 Azithromycin
K1 Bacterial coinfection
K1 Influenza
K1 Infection
K1 Adults
K1 Sars-cov-2
K1 Guideline
K1 Pneumonia
K1 Virus
AB Background Since December 2019, the COVID-19 pandemic has changed the concept of medicine. This work aims to analyze the use of antibiotics in patients admitted to the hospital due to SARS-CoV-2 infection. Methods This work analyzes the use and effectiveness of antibiotics in hospitalized patients with COVID-19 based on data from the SEMI-COVID-19 registry, an initiative to generate knowledge about this disease using data from electronic medical records. Our primary endpoint was all-cause in-hospital mortality according to antibiotic use. The secondary endpoint was the effect of macrolides on mortality. Results Of 13,932 patients, antibiotics were used in 12,238. The overall death rate was 20.7% and higher among those taking antibiotics (87.8%). Higher mortality was observed with use of all antibiotics (OR 1.40, 95% CI 1.21-1.62; p
PB Bmc
YR 2021
FD 2021-11-08
LK https://hdl.handle.net/10668/26563
UL https://hdl.handle.net/10668/26563
LA en
DS RISalud
RD Feb 24, 2025